A randomized controlled trial showed that the average phototherapy time required by infants receiving AP-32 was approximately 7 h less than that of the placebo group, and the CP-9 group also showed a trend of shortened treatment time ( Tsai et al., 2025 ).
← all excerpts
Bilirubin-microbiota interaction: molecular mechanisms and therapeutic strategies in neonatal jaundice.
1
—
—